Chandan Dharmashekara, Sabhyata M. Gopal, Gayatri Vaidya, Bhargav Shreevatsa, H. H. Bhavana, Chandrashekar Srinivasa, S. M. Gopinath, Shiva Prasad Kollur, Sharanagouda S. Patil, Kuralayanapalya Puttahonnappa Suresh, Raghu Ram Achar, Ashwini Prasad & Chandan Shivamallu·Journal of Pharmaceutical Research International·2021
Background: Leptospirosis is a disease that is zoonotic in nature. It is easily able to survive in the environment and gets transmitted from the reservoir hosts such as rat to humans. Though the cause of Leptospira interrogans virulency is not determined, these studies expresses...
Open access
Research Article10.9734/jpri/2021/v33i60B34635
Akshatha C, Gayatri Vaidya, Chandan Dharmashekara, Bhargav Shreevatsa, H. S. Vikas, H. H. Bhavana, Kollur Shiva Prasad, Chandrashekar Srinivasa, Sharanagouda S. Patil, S. Bindya, P. Ashwini, Pallavi M, Chandan Shivamallu & Raghu Ram Achar·Journal of Pharmaceutical Research International·2021
COVID-19's recent appearance in Wuhan, China, has affected more than three million twenty-five million individuals worldwide. It is considered a pandemic disease by WHO. Till now, there is no approved therapeutic for treating COVID-19 infection. The involvement of RNA-dependent R...
Open access
Research Article10.9734/jpri/2021/v33i60B34690
H. M. Akshay, Gayatri Vaidya, Sarika M. Sheety, Chandan Dharmashekara, Bhargav Shreevatsa, Siddesh V. Siddalingegowda, Poojitha B. Sridhara Setty, Chandrashekar Srinivasa, Poojitha B. Sridhara Settee, Sharanagouda S. Patil, S. Bindya, Shiva Prasad Kollur, P. Ashwini & Chandan Shivamallu·Journal of Pharmaceutical Research International·2021
Background: The World Health Organization (WHO) declared Coronavirus disease 2019 (COVID-19), as a pandemic in January 2020. The morbidity and mortality associated with the disease are enormous COVID-19, with a multi-systemic pathology, exhibits thrombosis as a common manifestati...
Open access
Research Article10.9734/jpri/2021/v33i52A33550